-
Featured
Confronting the Opioid Epidemic in the OB/GYN Practice: Optimizing Prescribing Habits and Reducing Opioid Misuse
Researchers in the OB/GYN Department are working to combat the opioid epidemic and mitigate its effects. Recent efforts have focused on preventing opioid use and misuse through a variety of methods including optimized prescribing practices.
-
Featured
Fighting Zika Virus on Multiple Fronts: Identifying Risk, Improving Screening and Investigating Pregnant Women's Vaccination Attitudes
Obstetricians at Mass General are working to fight the Zika epidemic on multiple fronts by guiding decision-making about testing for Zika infection, filling knowledge gaps about Zika risks and develop testing protocols and understanding pregnant women’s attitudes about Zika vaccines to help guide vaccine development.
-
Featured
Perinatal Substance Use Clinic: Multidisciplinary Care from Pregnancy to Early Childhood
A multidisciplinary, 1000-day clinical model offers a new approach to prenatal and postnatal care for mothers with opioid use disorder and their children.
-
Bridging the Gap in Cardiovascular Disease During Pregnancy
Amy Sarma, MD, cardiologist in the Corrigan Women's Heart Health Center, discusses her research of cardiovascular disease in women and the importance of collaboration between cardiology and obstetrics in preventing maternal mortality.
-
Time to Delivery After PROM at Term Is Shorter with Oxytocin than Buccal Misoprostol
Among nulliparous women presenting with prelabor rupture of membranes at term and unfavorable cervical dilation, oxytocin was associated with a significantly shorter admission-to-delivery interval and fewer vaginal exams compared with buccal misoprostol.
-
High Fetal Fraction in First Trimester May Be Useful Marker of Fetal Growth Restriction
Mass General researchers are the first to demonstrate that high fetal fraction with cell-free DNA on first trimester aneuploidy screening predicts infant birth weight of less than the fifth percentile.
Obstetrics contributors
-
Davida M. Schiff, MD
Medical Director, HOPE Clinic, Instructor, Pediatrics, Harvard Medical School
Recent Article
Perinatal Substance Use Clinic: Multidisciplinary Care from Pregnancy to Early Childhood
-
Ilona T. Goldfarb, MD
Maternal Fetal Medicine Specialist
Recent Article
High Fetal Fraction in First Trimester May Be Useful Marker of Fetal Growth Restriction
-
Jeffrey L. Ecker, MD
Chief, Department of Obstetrics & Gynecology
Recent Article
Confronting the Opioid Epidemic in the OB/GYN Practice: Optimizing Prescribing Habits and Reducing Opioid Misuse
-
Jessica R. Gray, MD
Clinical director, HOPE Clinic, Family medicine addiction specialist
Recent Article
Perinatal Substance Use Clinic: Multidisciplinary Care from Pregnancy to Early Childhood
-
Sarah N. Bernstein, MD
Maternal Fetal Medicine Specialist, Medical director, Outpatient Obstetrics Program
Recent Article
Perinatal Substance Use Clinic: Multidisciplinary Care from Pregnancy to Early Childhood
-
William H. Barth, MD
Vice Chair, Obstetrics
Recent Article
Liposomal Bupivacaine Block Similar to Placebo for Pain Reduction After Cesarean
Obstetrics & Gynecology Care at Mass General
The Mass General Department of Obstetrics & Gynecology offers the highest level of care to women. Our clinical and research team is a leader in advancing treatments for gynecologic cancers, menopause, high-risk obstetrics, infertility and urogynecology.
